Anixa Biosciences, Inc. (ANIX) Discusses Differentiated CAR-T Therapy and Breast Cancer Vaccine Clinical Programs Transcript

PresentationRobert SassoonWater Tower Research LLC Hello, everybody. I'm Robert Sassoon. I cover health care at Water Tower Research. Today, I have the pleasure of being joined in this fireside chat by Anixa Biosciences' Chairman and CEO, Dr. Amit Kumar. Anixa is a clinical stage biotech company, which develops a novel type of CAR-T cell therapy for the treatment of termly ill ovarian cancer patients and separately, a vaccine for the treatment and prevention of breast cancer. Anixa has also additional pred ...